Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02170090
What this trial is testing

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaGall Bladder Carcinoma
Universitätsklinikum Hamburg-Eppendorf 789
Not applicableLooking for participantsNCT05428345
What this trial is testing

Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Who this might be right for
Ulcerative ColitisCrohn's DiseaseInflammatory Bowel Disease (IBD)
Takeda 600
Not applicableStudy completedNCT03102307
What this trial is testing

Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)

Who this might be right for
Early Stage Breast Cancer
Kliniken Essen-Mitte 548
Testing effectiveness (Phase 2)Ended earlyNCT01248299
What this trial is testing

Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Centre Oscar Lambret 105
Not applicableStudy completedNCT00000914
What this trial is testing

The Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 800
Large-scale testing (Phase 3)Study completedNCT01207011
What this trial is testing

Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sumitomo Pharma Co., Ltd. 202
Not applicableStudy completedNCT04887519
What this trial is testing

Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell LungAnaplastic Lymphoma Kinase
Takeda 39
Not applicableLooking for participantsNCT06902467
What this trial is testing

Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)

Who this might be right for
Ovarian Cancer
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 20
Early research (Phase 1)Study completedNCT02959892
What this trial is testing

A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)

Who this might be right for
Healthy Volunteers
Neurocrine Biosciences 12
Testing effectiveness (Phase 2)Study completedNCT00868608
What this trial is testing

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma
Pfizer 81
Testing effectiveness (Phase 2)Study completedNCT00285389
What this trial is testing

Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years

Who this might be right for
Mantle Cell Lymphoma
French Innovative Leukemia Organisation 39
Not applicableStudy completedNCT03826589
What this trial is testing

Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy

Who this might be right for
Cervical Cancer
The University of Hong Kong 23
Not applicableUnknownNCT04122885
What this trial is testing

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

Who this might be right for
Peritoneal CancerChemotherapy-Induced Change
University Hospital Tuebingen 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT07586813
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGastrointestinal Neoplasms+2 more
Peking University People's Hospital 220
Not applicableUnknownNCT00488722
What this trial is testing

A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University
Early research (Phase 1)Looking for participantsNCT03692429
What this trial is testing

AlloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

Who this might be right for
Unresectable Metastatic Colorectal Cancer
Celyad Oncology SA 49
Post-approval studies (Phase 4)UnknownNCT05949333
What this trial is testing

Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy

Who this might be right for
Breast Neoplasms
Eunseong Medical Foundation Good GANG-AN HOSPITAL 100
Large-scale testing (Phase 3)Study completedNCT00820755
What this trial is testing

Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Merck KGaA, Darmstadt, Germany 583
Large-scale testing (Phase 3)Active Not RecruitingNCT05776758
What this trial is testing

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

Who this might be right for
Muscle-Invasive Bladder CarcinomaChemotherapy EffectSurgery
Regina Elena Cancer Institute 236
Next Page
35